[144] Mind Medicine (MindMed) Inc. SEC Filing

Rhea-AI Filing Summary

Mind Medicine (MindMed) Inc. (MNMD) – Form 144 notice.

The filer intends to dispose of 11,491 common shares through Morgan Stanley Smith Barney LLC on 25 June 2025 via NASDAQ. These shares were acquired the same day through restricted-stock vesting under a registered compensation plan. The proposed sale has an aggregate market value of $78,169.83, versus 75,553,266 shares outstanding, making the transaction equivalent to roughly 0.02 % of total shares.

The filer reports no other share sales in the past three months and certifies awareness of no undisclosed adverse information. The submission is flagged as LIVE. Overall, the event signals a routine liquidity move rather than a materially dilutive or strategic development.

Insights

Securities Analyst

TL;DR: Small Rule 144 sale (~$78k) is immaterial to MNMD’s float; neutral for valuation.

The notice covers 11,491 shares, about 0.02 % of the company’s 75.6 M outstanding. Such size neither pressures liquidity nor signals significant insider sentiment change. The shares stem from normal equity compensation, aligning with routine insider diversification. No concurrent sales were reported over the prior quarter, reducing concerns of broader insider selling trends. Absent earnings, guidance, or strategic context, the filing carries negligible financial impact and should be viewed as housekeeping disclosure.

Corporate Governance Expert

TL;DR: Governance perspective—routine disposal; no red flags detected.

Because the securities originate from vested restricted stock, the sale is consistent with standard executive remuneration practices. The filer affirmatively states no knowledge of undisclosed material information, satisfying Rule 144 and 10b5-1 safeguards. With no pattern of sequential sales and an immaterial stake, the action does not indicate governance or control shifts. Therefore, investors should treat this as administratively neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11491	78169.83	75553266	06/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2025	Restricted stock vesting under a registered plan	Issuer			11491	06/25/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MindMed (MNMD) shares are being sold under this Form 144 filing?

11,491 common shares are proposed for sale.

What is the aggregate market value of the planned MNMD share sale?

The filing lists an approximate value of $78,169.83 for the 11,491 shares.

What percentage of MindMed’s outstanding shares does the sale represent?

It equals roughly 0.02 % of the 75,553,266 shares outstanding.

When is the anticipated sale date for the MNMD shares?

The approximate sale date disclosed is June 25, 2025.

Were any other MNMD shares sold by the filer during the past three months?

No. The form explicitly states "Nothing to Report" for prior three-month sales.